Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. The company is headquartered in Boca Raton, Florida and currently employs 7 full-time employees. The company went IPO on 2009-03-31. The firm designs, develops and markets neurological medical devices and therapies. The firm operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage, such as that caused by a stroke. Vycor Medical’s ViewSite Brain Access System (VBAS) is a next-generation retraction and access system. VBAS is a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system is used in over 300 hospitals in the United States and in numerous countries internationally. NovaVision products include Visual Restoration Therapy (VRT) and NeuroEyeCoach.
VYCO stock price ended at $0.14 on 금요일, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of VYCO rose by 0.00%, climbing from $0.14 to $0.14. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.14 and a high of $0.14. Notably, trading volume dropped by 2.8K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 5.0K shares were traded, equating to a market value of approximately $4.6M.
VYCO 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 2
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
VYCO은 현재 2개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
VYCO에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 VYCO 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.